Category Archives: Hormone Replacement Therapy

HER2 testing offers the advantage in determining and validating the biopsy by screening the sample for HER2 test offering advantage to the physicians in treatment and operating. The conventional method involves histochemical screening. Continue reading →

Christophe Hzode,1 Paul Kwo,2 Jan Sperl,3 Peggy Hwang,4 Jianmin Long,4 Rohit Talwani,4 Michael N Robertson,4 Barbara A Haber4 1Service dHpatologie, Hpital Henri-Mondor, AP-HP, Universit Paris-Est, INSERM U955, Crteil, France; 2Division of Gastroenterology/Hepatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA, USA; 3Department of Hepatogastroenterology, Institut Klinick a Experimentln Medicny (IKEM), Prague, Czech Republic; 4Department of Infectious Disease, Merck & Co., Inc., Kenilworth, NJ, USA Correspondence: Christophe Hzode Service dHepatologie, Hpital Henri Mondor, 51, avenue du Marchal de Lattre de Tassigny, Crteil 94010, France Tel +33 14 981 2111 Email christophe.hezode@aphp.fr Introduction: Some direct-acting antiviral regimens for hepatitis C virus (HCV) infection pose safety or efficacy concerns if coadministered with drugs containing ethinyl estradiol. The present analysis was conducted to examine the impact of concomitant oral contraceptive pills (OCP) or hormone replacement therapy (HRT) during treatment with elbasvir (EBR)/grazoprevir (GZR) in women with HCV genotype (GT)1 or GT4 infection. Methods: This is a post hoc, integrated retrospective analysis of female participants with HCV GT1 or GT4 infection who received EBR 50mg/GZR 100mg once daily for 12weeks in phase 2/3 clinical trials. Continue reading →

This extensive analysis sheds light on an array of intangible aspects connected with the business such as important definitions, end use and total revenue garnered across different regions. The researcher has taken a conscious effort to get a closer look at some of the top performers of the Hormone Replacement Therapy industry. Other essential aspects evaluated during research include import and export, demand and supply, distribution channel, gross margin and supply chain management Continue reading →

Long overlooked, menopause starts to get noticed as doctors and entrepreneurs see a market ripe for disruption. Women are desperate to figure out why they dont feel good. Continue reading →

A leading research firm, Zion Market Research added a latest industry report on "Global Hormone Replacement Therapy Market" consisting of 110+ pages during the forecast period and Hormone Replacement Therapy Market report offers a comprehensive research updates and information related to market growth, demand, opportunities in the global Hormone Replacement Therapy Market. According to the report the Global Hormone Replacement Therapy Market Growth Driver 2016 2024: By Pfizer, BioSante Pharmaceuticals and Amgen, Noven Pharmaceuticals, Bayer AG, Merck & co., and QuatRx Pharmaceuticals. Pfizer, BioSante Pharmaceuticals and Amgen, Noven Pharmaceuticals, Bayer AG The Hormone Replacement Therapy Market report provides in-depth analysis and insights into developments impacting businesses and enterprises on global and regional level. Continue reading →

At menopause, a womans ovaries lose their reproductive function. Continue reading →

Post navigation Future Market Insights, in a recently published study on the global Hormone Replacement Therapy Market, provides an in-depth assessment of the multiple elements of the market that are expected to shape the growth of the market in the upcoming years. Further, the key factors that are projected to influence the overall dynamics of the Hormone Replacement Therapy Market including the current trends, growth opportunities, market drivers, and restraints are thoroughly discussed in the report. As per the findings of the report, the Hormone Replacement Therapy Market is projected to reach a value of ~US$XX by the end of 2019 and likely to grow at a CAGR of ~XX% in the forecast period 2017 2027 Continue reading →

Within five minutes of sitting down with Meg Mathews, shes talking about vaginal dryness and the wonders of lubricant as casually as if she were discussing last nights Corrie. Having been a menopause campaigner for the last two years, Meg doesnt flinch at this stuff and rolls her eyes at the squeamishness over the language we use when it comes to female biology. Continue reading →

Caitlyn Jenner is said to be the highest-paid I'm a Celebrity Get Me Out of Here contestant this year. And a whole generation will know her from reality series Keeping Up with the Kardashians, which made global stars out of the Kardashian family. Continue reading →

Menopause is not a disease or a disorder. Continue reading →